The Treatment

Theatre
Theatres at 45 Bleecker/Bleecker Street Theatre (New York, NY)
45 Bleecker St.
New York, NY 10012
Social / Subscribe


Buy Tickets - Closed Show
Seating Chart
Grosses
CDS/Books/DVDs
Articles

Varian Medical Systems' ASTRO Exhibit Spotlights Technology and Software that Support Knowledge Sharing Among Oncology Professionals
by BWW News Desk - Sep 9, 2014

SAN FRANCISCO, Sept. 9, 2014 /PRNewswire/ ASTRO Booth #807 Varian Medical Systems (NYSE: VAR) will showcase technologies developed to support knowledge sharing among oncology professionals at the meeting of the American Society for Radiation Oncology (ASTRO) here next week. The Varian exhibit will highlight software and services that enable information sharing and data analytics to support more efficient, higher-quality cancer care. (more...)

American Academy of Orthopaedic Surgeons releases criteria and a mobile app for optimally treating broken elbows in children
by BWW News Desk - Sep 9, 2014

ROSEMONT, Ill., Sept. 9, 2014 /PRNewswire-USNewswire/ The American Academy of Orthopaedic Surgeons (AAOS) today released new Appropriate Use Criteria (AUC) and a mobile app for The Treatment of pediatric supracondylar humerus fractures (elbow fractures in children), to aid trauma and emergency department doctors and orthopaedic residents in The Treatment of these complex injuries. (more...)

BWW Reviews: SPARK Shows Promise at Theater Alliance
by Jennifer Perry - Sep 9, 2014

'Spark' doesn't ignite, but it doesn't fizzle either. (more...)

BWW Review: THE LAST FIVE YEARS Movie is a Marvelous Adaptation of Jason Robert Brown's Off-Broadway Musical
by Alan Henry - Sep 8, 2014

The film adaptation of 'The Last Five Years,' based on the musical by Jason Robert Brown, had its world premiere last night at the Toronto International Film Festival. 'The Last Five Years' is a musical chronicling a relationship taking place over a five year period. Jamie Wallerstein is a young, talented up and coming novelist who falls in love with Cathy Hiatt, a struggling actress. Their story is told almost entirely through song. All of Cathy's songs begin at the end of their marriage and move backwards in time to the beginning of their love affair, while Jamie's songs start at the beginning of their affair and move forward to the end of their marriage. They meet in the center when Jamie proposes. (more...)

MMRGlobal Announces Claim Construction Order Adopts Six of Eight Plaintiff Proposed Claim Terms
by BWW News Desk - Sep 8, 2014

LOS ANGELES, CA(Marketwired - Sep 8, 2014) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, 'MMR'), today announced that on September 3, 2014, a Claim Construction Order was issued in the consolidated patent infringement suits between plaintiff MyMedicalRecords, Inc., and defendant(s) Quest Diagnostics, Inc., Empty Jar, LLC f/k/a Jardogs, LLC, Allscripts Healthcare Solutions, Inc., and WebMD Health Corp. and WebMD Health Services Group. MMR now looks forward to proceeding with discovery and preparing for trial. (more...)

New Recess Reports Help Political Journalists and Policy Pros Jump Back into Congress
by BWW News Desk - Sep 5, 2014

WASHINGTON, Sept. 5, 2014 /PRNewswire/ Jumping back into Congress after the summer recess will be easier with four new Recess Reports available from VoteTocracy, a nonpartisan policy platform. Senior researchers highlighted the key legislation and critical issues facing lawmakers when they return, as well as the legislative ramifications of a Republican takeover in the House and Senate in November. The Recess Reports include: (more...)

BreakThrough Physical Therapy Supports Brenner FIT 5K Challenge
by BWW News Desk - Sep 4, 2014

(more...)

New WCRI Study Monitors Trends in New York Workers' Compensation System
by BWW News Desk - Sep 4, 2014

Trends in the performance of the New York workers' compensation system following reforms enacted in 2007 are monitored in a new study from the Workers Compensation Research Institute (WCRI). The regular monitoring of system performance helps policymakers and system stakeholders focus attention on the objectives that are being met, objectives that are not being met, and any unintended consequences that have emerged. (more...)

SoundCure Announces Results of Randomized Clinical Study: S-Tones Found to be More Effective Than Broadband Noise in Reducing Tinnitus
by BWW News Desk - Sep 4, 2014

The study, conducted by leading tinnitus researchers at three top audiology centers, and led by internationally renowned Dr. Richard Tyler of the University of Iowa, found that a majority of patients showed a greater reduction in tinnitus perception using S-Tones, even at soft volume levels below their tinnitus perception, when compared with broadband noise. Accordingly, the study concluded that S-Tones "are effective in more patients than broadband noise maskers at reducing tinnitus loudness, and therefore have the potential to be beneficial to a large segment of the tinnitus population." (more...)

BIND Therapeutics Appoints Two New Board Members
by BWW News Desk - Sep 3, 2014

Eric K. Rowinsky, M.D., currently serves as Head of Research and Chief Medical Officer at Stemline Therapeutics and as a board member of Biogen Idec Inc. and was formerly Executive Vice President of Clinical Development and Regulatory at ImClone Systems. Amy W. Schulman is the Chief Executive Officer of Arsia Therapeutics and a Venture Partner at Polaris Partners. She is the former Executive Vice President and General Counsel of Pfizer Inc. and served as the Business Unit Lead for Pfizer's Consumer Healthcare business, after serving as President of the Nutrition Business, which was sold to Nestle for $11.85 billion. (more...)

CDC Director Warns 'Must Act Now' on Ebola Epidemic on CBS THIS MORNING
by TV News Desk - Sep 2, 2014

Centers for Disease Control Director Dr. Thomas Frieden warned that the Ebola epidemic which has spread throughout Western Africa is “spiraling out of control,” in an interview that was broadcast live today, Sept. 2, 2014, on CBS THIS MORNING (7:00-9:00 AM) on the CBS Television Network. (more...)

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes
by BWW News Desk - Sep 2, 2014

BARCELONA, Spain, Sept. 2, 2014 /PRNewswire/ Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced data from a subgroup analysis of the phase 3 ENGAGE AF-TIMI 48 study, that explores the relationship between edoxaban dose, concentration and anti-factor Xa activity in patients with non-valvular atrial fibrillation (NVAF). The analysis also compared rates of major bleeding and efficacy outcomes [stroke and systemic embolic events (SEE)] of edoxaban versus warfarin, stratified by dose reduction status. (more...)

Marine Corps Combat Veteran and Spartan Races Endorse Topricin Pain Relief and Healing Creams
by BWW News Desk - Sep 19, 2014

Rhinebeck, NY (more...)

Actions Semiconductor Announces Preliminary Results of its Tender Offer
by BWW News Desk - Sep 19, 2014

ZHUHAI, China, Sept. 19, 2014 /PRNewswire/ Actions Semiconductor Co., Ltd. (ACTS) ('Actions Semiconductor' or the 'Company'), one of China's leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, announced today the preliminary results of its previously announced 'Dutch auction' tender offer for the purchase for cash up to 60,000,000 of its issued and outstanding ordinary shares (the 'Shares') (including Shares represented by American Depositary Shares (the 'ADSs', together with the Shares, the 'Securities')), at a purchase price not greater than $7/15 per Share (or $2.80 per ADS) nor less than $5/12 per Share (or $2.50 per ADS), which expired at 5:00 P.M., Eastern Daylight Savings time, on Thursday, September 18, 2014. (more...)

Nexstim Launches Next Generation NBS 5 System
by BWW News Desk - Sep 18, 2014

HELSINKI, Finland, September 18, 2014 /PRNewswire/ (more...)

VIDEO: RED BAND SOCIETY's Octavia Spencer & Rutger's Marching Band Visit NY Children's Hospital
by TV News Desk - Sep 17, 2014

Below, the actress is joined by Rutger's Marching Band as the visit a New York Children's Hospital. (more...)

OKI Delivers Additional Exhaust Gas Treatment Equipment for ON Semiconductor's European Plants
by BWW News Desk - Sep 16, 2014

Thus, it ensures reliability and consistency in the CVD thin film manufacturing line, ultimately helping to maintain the customer's production environment. (more...)

Actor James Van Der Beek and AstraZeneca Join Forces to Educate Families about Influenza
by BWW News Desk - Sep 15, 2014

WILMINGTON, Del., Sept. 15, 2014 /PRNewswire/ AstraZeneca announced today that it has collaborated with actor and father James Van Der Beek on a campaign to dispel common myths about the flu and underscore the importance of annual influenza vaccination for eligible individuals and families. As part of the campaign, Van Der Beek stars in an informative and comedic video, called 'Just the Flu Facts,' in which he uses his signature sense of humor to debunk common misconceptions about seasonal influenza that are often barriers to vaccination. (more...)

Frost & Sullivan Commends APATEQ's Pioneering Integrated Membrane System for the European Advanced Filtration Technology Market
by BWW News Desk - Sep 15, 2014

LONDON, Sept. 15,2014 /PRNewswire/ Based on its recent analysis of the advanced filtration technology market, Frost & Sullivan is proud to present APATEQ with the 2014 European Technology Innovation Leadership Award. (more...)

Mitsubishi Electric to Deliver Pencil Beam Scanning System for Cancer Therapy at SAGA Heavy Ion Medical Accelerator
by BWW News Desk - Sep 12, 2014

Pencil Beam Scanning is a next generation technology that uses a carbon ion beam with drastically reduced spot size to more accurately and efficiently irradiate complicated tumor volumes. The system enables the delivery of individual layers of pencil beam spots to precise locations, eliminating the need for beam collimation and compensators to adjust the target area. As a result, it provides greater efficiency in time and cost in setting up The Treatment fields and improved throughput, as well as increased patient benefit. (more...)

SlimBodyXpress Launches the "Next Generation" of Body Contouring
by BWW News Desk - Sep 11, 2014

Women and men across the country have been searching for a way to slim, tighten, and tone their body shape without a cosmetic surgery procedure like liposuction or without the cost, time or discomfort seen with coolsculpting, radio frequency or liposonix. While hundreds of products are on the market claiming to do just that, a new technology that produces measurable results based on science has just been introduced in the Coachella Valley, California at Desert Health & Wellness (www.SlimBodyXpress.com). This new technology, SlimBodyXpress, is a combination of two FDA approved therapies - infrared therapy and Cellulite EMS that delivers completely noninvasive fat removal, inch loss and cellulite reduction as well as toning, firming and tightening. 'The word 'revolutionary' gets thrown around a lot in the field of aesthetic medicine, especially in the context of laser and light-based treatments,' notes Dr. Ron Ristaino, DC, founder of Desert Health & Wellness. 'But after carefully reviewing the scientific studies and available literature, and seeing the system in action, I can wholeheartedly say that SlimBodyXpress is a revolutionary treatment for my patients who want to enhance their body shape without going under the knife.' In their clinical studies, patients receiving SlimBodyXpress, on average lost up to 16 inches and up to 6 clothing sizes in a very short period of time. The science behind this Coachella Valley body contouring technique is sound,' says Dr. Ron Ristaino. 'It may be hard for some people to believe, but science is now able to shape the body without surgery, without a strict diet, and without a rigorous exercise routine. The procedure requires no anesthesia or incisions, and within less than an hour in most cases your treatment session will be finished and you'll be able to carry on with your day.' The SlimBodyXpress device causes the formation of what is called a 'transitory pore' in the membrane of a fat cell. Through this pore, fat from the cell is released into the body, where it is safely carried away by the body's own natural cleansing process. Surgical extraction of the fat is not required. 'Because there's no need to break up and suction out the fat cells, as with a traditional liposuction procedure, aftereffects like swelling, bruising, and temporary soreness in the treated areas are eliminated,' says Dr. Ristaino. 'A series of treatments is required over several weeks, but patients are finding that this time commitment is a small sacrifice for the long-term body contouring benefits The Treatment can provide.' At Desert Health & Wellness (www.SlimBodyXpress), Dr. Ron Ristaino and staff offer innovative body contouring techniques. They also perform other popular non-invasive procedures including non-invasive microcurrent facelifts. About SlimBodyXpress SlimBodyXpress is a unique total body system, developed for the medical, health and wellness industry. In a relatively short time, the SlimBodyXpress Non-Invasive System is becoming incredibly sought after and respected not only in spas around the globe, but also in medical offices, salons, and wellness centers. (more...)

Varian Treatment Planning Support for Siemens Modulated Arc (mARC) Treatments to be Highlighted at 2014 ASTRO Meeting in San Francisco
by BWW News Desk - Sep 11, 2014

SAN FRANCISCO, Sept. 11, 2014 /PRNewswire/ Varian Medical Systems (NYSE: VAR) and Siemens Healthcare will showcase a variety of solutions that bring together Siemens' leading diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, proton therapy, and brachytherapy at the 55th annual meeting of the American Society for Radiation Oncology (ASTRO) starting here this Sunday. (more...)

William L. Mince, COO of LiveLeaf, Inc. Releases UP FROM THE CROWD
by BWW News Desk - Sep 11, 2014

MENLO PARK, Calif. (more...)

Camden People's Theatre Presents CALM DOWN, DEAR Festival of Feminism, Sept 24-Oct 12
by BWW News Desk - Sep 1, 2014

Camden People's Theatre's Calm Down, Dear, The Festival of Feminism returns for a second year of theatre, performance, comedy, cabaret, dance and discussion at Camden People's Theatre, 24th September to 12th October. (more...)

Drexel Theatre to Host Talk-Back Following ALIVE INSIDE Screening, 9/4
by BWW News Desk - Aug 8, 2014

Following the 7pm debut screening of Alive Inside on Thursday, September 4, the Drexel Theatre will hold an audience talk-back to discuss the effects of music in The Treatment of patients suffering from Alzheimer's disease and other dementias. Panel members will include Bonnie K. Burman, Sc.D., director of the Ohio Department of Aging; Peter J. Whitehouse, MD, PhD, professor of neurology at Case Western Reserve University and the University of Toronto; Dan Cohen, founder and executive director of Music & Memory; and Salli Bollin, executive director of the Northwest Ohio Chapter of the Alzheimer's Association. (more...)

BIND Therapeutics Reports Second Quarter 2014 Financial Results
by BWW News Desk - Aug 7, 2014

“We remain on track with BIND-014, our lead proprietary drug candidate, by continuing enrollment in the weekly dosing schedule of BIND-014 in our Phase 2 non-small cell lung cancer trial and expect to report top line data on the every three week dosing schedule from both the lung and metastatic castrate resistant prostate cancer Phase 2 trials in the fourth quarter of this year. In addition, we are continuing to make good progress toward our goals of significantly expanding our BIND-014 development program by initiating two additional Phase 2 trials in KRAS mutant non-small cell lung cancer and in a number of other solid-tumor indications before the end of 2014,” said Andrew Hirsch, BIND's Chief Operating Officer. (more...)

Retired Navy SEAL Still in the Fight for Fellow Warriors
by BWW News Desk - Aug 7, 2014

Over the next nine months, retired Navy Senior Chief Mike Day will be raising funds to provide his fellow wounded warriors with access to leading edge treatment programs for debilitating brain injuries. (more...)

Stephen Lee Anderson, Stephen Bogardus, Patti Cohenour and More to Lead Steve Martin's BRIGHT STAR at The Old Globe; Walter Bobbie Directs!
by BWW News Desk - Aug 6, 2014

The Old Globe today announced the full cast and creative team for the World Premiere of Bright Star, a new American musical featuring music by Edie Brickell and Steve Martin, lyrics by Brickell, and book by Martin, based on an original story by Martin and Brickell. Directed by Walter Bobbie, Bright Star will run September 13 - November 2, 2014 on the Donald and Darlene Shiley Stage in the Old Globe Theatre, part of the Globe's Conrad Prebys Theatre Center. Preview performances run September 13 - September 27. Opening night is Sunday, September 28 at 7:00 p.m. Single tickets go on sale on Friday, August 8 at noon. (more...)

MMRGlobal to Grant Royalty-Free Licenses to Universities to Research Ebola Therapies Using Company's Patented Monoclonal Antibody Technology
by BWW News Desk - Aug 5, 2014

LOS ANGELES, CA(Marketwired - Aug 5, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ('MMR') today announced that the Company plans on granting royalty-free licenses to universities interested in using the Company's patented antibody technology for research and development into potential therapies in the fight against Ebola. (more...)

Mitchell Releases Third Quarter 2014 Industry Trends Report
by BWW News Desk - Aug 5, 2014

SAN DIEGO, CA(Marketwired - Aug 5, 2014) - Mitchell, a leading provider of technology, connectivity and information solutions to the Property & Casualty (P&C) claims and Collision Repair industries, today announced the availability of its Industry Trends Report (ITR) for the third quarter of 2014. The report identifies and examines the latest trends in the industry, while comparing current market data to old figures to help P&C insurers, bill reviewers, payers and auto body repair shops better understand the landscape and make business decisions using the information. (more...)

Communications & Power Industries Receives $5.6 Million to Support Airborne Electronic Warfare System
by BWW News Desk - Aug 5, 2014

PALO ALTO, Calif., Aug. 5, 2014 /PRNewswire/ The Radant Technologies Division of Communications & Power Industries LLC (CPI) has recently been awarded orders totaling $5.6 million to provide two different types of radomes for an airborne electronic warfare system. (more...)

LOVE NOTES FROM HELL By Roy Nelson Set for Release, October 2014
by BWW News Desk - Aug 29, 2014

Everyone has vices – negative habits they turn to when life becomes stressful. Some take these vices to the extreme and turn into full-on addicts: food, drugs, sex, alcohol, gambling or shopping to mask or numb the pain. Those trying to overcome the addiction could spend years in and out of treatment programs, 12 step rooms and therapy, but still continue to struggle with their demons. (more...)

Botanica Day Spa in Clearwater, FL Adds Cupping Massage to List of Services
by BWW News Desk - Aug 29, 2014

Clearwater, FL (more...)

Nanotechnology Market Outlook 2020
by BWW News Desk - Aug 28, 2014

NEW YORK, Aug. 28, 2014 /PRNewswire/ Reportlinker.com announces that a new market research report is available in its catalogue:Nanotechnology Market Outlook 2020 http://www.reportlinker.com/p02162665/Nanotechnology-Market-Outlook-2020.html (more...)

BIND Therapeutics to Present Data at the 26th EORTC-NCI-AACR Symposium
by BWW News Desk - Aug 26, 2014

BIND-014 is a PSMA targeted polymeric nanoparticle containing the cytotoxic agent docetaxel. In preclinical cancer models, BIND-014 was shown to increase accumulation of docetaxel in tumors which translated to marked improvements in antitumor activity. In a Phase 1 study, BIND-014 was well tolerated and showed initial indications of anti-tumor activity. BIND-014 is currently in two Phase 2 trials for The Treatment of non-small cell lung cancer and metastatic castrate resistant prostate cancer. (more...)

New Vitality Health Foods Offers Tips On Nutritional Supplements for Kids
by BWW News Desk - Aug 26, 2014

Orland Park, Il (more...)

Big Belli and Dr. Smith's to Partner for Production of '40 Weeks' Documentary
by BWW News Desk - Aug 26, 2014

Big Belli, parenting content media brand, and Dr. Smith's, a beloved diaper rash brand, have announced today that they have entered into a strategic partnership to help guide expecting mothers through the journey of pregnancy. Dr. Smith's will serve as a sponsor of Big Belli's soon-to-be-released '40 Weeks' documentary. (more...)

BWW Reviews: WE PLAY CHEKHOV is Reader's Theatre at its Finest
by Jeff Davis - Aug 22, 2014

There's a sad phenomenon that occurs when an artist shows extreme talent and brilliance in one artistic medium. We tend to reward that talent by unjustly pigeonholing that artist into that medium alone. Case in point: Chekhov. We revere the Russian artist as a playwright, but we forget that he wrote an abundance of short stories as well. (more...)

Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application
by BWW News Desk - Aug 21, 2014

ANDOVER, Mass., Aug. 21, 2014 /PRNewswire/ Royal Philips (NYSE: PHG AEX: PHIA) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through 3D imaging, the Philips TAVI application provides interventionalists with pre-procedural, high-precision positioning to treat aortic stenosis ailments. (more...)

New Surgical Weight Loss Program Celebrates First Outpatient Lap-Band Procedure in Connecticut
by BWW News Desk - Aug 20, 2014

Darien, CT (more...)

Jackson Browne Announces New Album 'Standing In The Breach', Out 10/7
by BWW News Desk - Aug 20, 2014

On October 7th, Jackson Browne will release his 14th studio album, Standing In The Breach. The album was recorded in Los Angeles and features the single 'The Birds Of St. Marks,' (more...)

LIVESTRONG Launches the LIVESTRONG Cancer Institutes of The Dell Medical School at The University of Texas
by BWW News Desk - Aug 19, 2014

The LIVESTRONG Foundation announced today at a press conference on the campus of The University of Texas at Austin that it will be launching the LIVESTRONG Cancer Institutes to create an original model of patient-centered cancer care in partnership with the Dell Medical School. (more...)

Leroy Merlin Chooses MetricStream for Quality and EU Product Safety Compliance Management
by BWW News Desk - Aug 19, 2014

LONDON, Aug. 19, 2014 /PRNewswire/ Leroy Merlin, one of the world's largest Do-It-Yourself (DIY) home improvement retailers headquartered in France, and a subsidiary of the DIY giant, GROUPE ADEO, has selected MetricStream to provide a comprehensive solution for quality and product safety compliance management. MetricStream's solution will help Leroy Merlin streamline, automate, and integrate a range of quality assurance and product safety compliance processes, including quality audits, inspections, product compliance risk assessments, product testing, preventive actions, and curative actions such as The Treatment of non-compliance, product blocking, and recall management. (more...)

Galaxy Entertainment Group Reports Record Interim Results in 1H 2014
by BWW News Desk - Aug 19, 2014

HONG KONG, Aug.19, 2014 /PRNewswire/ Galaxy Entertainment Group Limited ('GEG' or 'the Group') (HKEx stock code: 27) today reported unaudited results for the three and six month periods ended 30 June 2014. (more...)

Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent for Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform
by BWW News Desk - Aug 14, 2014

"The '527 patent is another important protection for our multifaceted approach to improving drug development through diverse applications of our Single Cell Network Profiling platform," said Laura Brege, CEO and President of Nodality, Inc. "Nodality has carefully constructed a patent estate consisting of more than 30 issued and allowed patents in the US and abroad, with over 260 issued claims, particularly in relation to the detection of activatable proteins that can be analyzed in healthy and diseased tissues, as well as in response to the application of new therapeutic modalities. We believe we have a commanding IP position in our space, which is an important aspect of the value proposition we offer to current and potential collaborators." In addition to the issued and allowed patents, Nodality's intellectual property estate also consists of more than 60 patent applications both in the US and ex-US. (more...)

MagForce Publishes Financial Results for the First Half of 2014 and Operative Highlights
by BWW News Desk - Aug 14, 2014

Ben J. Lipps, CEO of MagForce, commented: “I am pleased to inform you that we are well on track, both in Europe and the US, and that I am very happy with MagForce's performance. With our EU-wide certification, we are planning to begin the commercial treatment of brain tumors in Germany sometime at the end of this year. In the US, from a long-term perspective, the greatest market potential comes from The Treatment of prostate cancer. In view of the extremely positive development we have experienced over the past ten months, I am convinced that we will meet our financial targets in Europe and North America. We are continuing our preparations for registration in the US and are planning to begin clinical trials in 2015. In August, we also successfully completed the first round of financing for MagForce USA, Inc. and raised USD 15 million with an additional USD 15 million in warrants to finance the development of the NanoTherm therapy in the US. I am delighted that we have managed to convince important strategic investors such as PayPal founder Peter Thiel to invest in MagForce USA.” (more...)

Abtech Holdings, Inc. Reports Second Quarter and First Half 2014 Financial Results
by BWW News Desk - Aug 13, 2014

SCOTTSDALE,Ariz., Aug. 13, 2014 /PRNewswire/ Abtech Holdings, Inc. (OTC QB: ABHD) ('AbTech' or the 'Company'), a full-service environmental technologies and engineering firm dedicated to providing innovative solutions to communities, industry and governments addressing issues of water pollution and contamination, today reported financial results for the three and six month periods ended June 30, 2014. (more...)

BioTime Announces Second Quarter 2014 Results and Recent Developments
by BWW News Desk - Aug 12, 2014

“We are pleased with our success to date in building toward our goal of developing both near-term commercial applications of our technologies and maintaining our focus on the power of pluripotent stem cells to create innovative human therapeutics,” said Dr. Michael D. West, BioTime's Chief Executive Officer. “Near-term product development underway includes our subsidiary OncoCyte Corporation's three cancer diagnostic products undergoing clinical studies, mobile health product development in our subsidiary LifeMap Solutions, Inc., our Renevia pivotal clinical trial in Europe, steps to prepare for the marketing of our recently FDA-cleared wound healing product Premvia, and growing research product sales by our ESI BIO division.” (more...)

BioTime Receives FDA Premarket Notification Clearance for Premvia 510(k)
by BWW News Desk - Aug 12, 2014

The global market for aesthetic and reconstructive surgery was estimated to exceed $6 billion annually and is composed of many distinct market segments. Premvia is expected to serve a subset of these segments. “We plan to rapidly complete the review and implementation of the requisite quality and manufacturing documentation in advance of introducing the product to the market. Additionally the Company will undertake selected clinical studies to further refine the target market niches, and following that, will lay our final plans for associated marketing initiatives and strategies,” said William Tew, Ph.D., BioTime's Chief Commercial Officer. “HyStem-based products such as Premvia and Renevia (the latter anticipated to begin its pivotal clinical trial in Europe later this year) are anticipated to provide the company with opportunities for significant near-term revenue, while balancing the long-term opportunities created by the Company's pluripotent stem cell technology platform, which provides the potential for the industrial-scale manufacture of all of the cellular components of the human body. Together, these matrices and cellular building blocks provide a combination of technology platforms that we believe can lead the industry in the revolution underway commonly called 'regenerative medicine.'” (more...)

TABB Says Global Fixed-Income Trading Regulatory Efforts Increasing Regionalization in Treatment of Collateral at Clearinghouses
by BWW News Desk - Aug 11, 2014

Clearing has become the main focus today for buy-side firms trading fixed income across the world's financial centers. As the report's author, TABB Group research analyst Radi Khasawneh, explains, there is now a bifurcation between clearinghouses with global reach and those with a domestic focus. However, he points out, this domestic focus can lead to a natural domestic bias, specifically for European entities that have the widest universe of accepted collateral. (more...)

 1  2  3  4 … 47